Capital - Disclosure of Share Warrants and Non-employee Warrants (Detail)
|
12 Months Ended |
|
Dec. 31, 2025
shares
€ / shares
|
Dec. 31, 2024
shares
|
Dec. 31, 2023
shares
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
13,367,451
|
|
|
| Number shares granted |
6,421,033
|
|
|
| Number of options/warrants exercised |
(13,438)
|
|
|
| Number of free shares vested |
(231,992)
|
|
|
| Number of instruments voided |
(3,081,364)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
16,461,689
|
13,367,451
|
|
| Maximum of shares to be issued |
16,981,708
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
7,641,653
|
|
|
| Stock options [member] | 3/24/2015 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/24/2015
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,336,826
|
|
|
| Number of instruments voided |
(1,336,826)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
1,336,826
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 38.45
|
|
|
| Stock options [member] | 9/8/2015 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
09/08/2015
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,301,000
|
|
|
| Number of instruments voided |
(1,301,000)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
1,301,000
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 27.55
|
|
|
| Stock options [member] | 3/14/2016 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/14/2016
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,261,336
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
1,261,336
|
1,261,336
|
|
| Maximum of shares to be issued |
1,337,016
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
1,261,336
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 22.44
|
|
|
| Stock options [member] | 10/28/2016 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
10/28/2016
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,440,646
|
|
|
| Number of instruments voided |
(2,704)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
1,437,942
|
1,440,646
|
|
| Maximum of shares to be issued |
1,524,220
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
1,437,943
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 17.9
|
|
|
| Stock options [member] | 10/11/2017 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
10/11/2017
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
665,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
665,000
|
665,000
|
|
| Maximum of shares to be issued |
704,900
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
665,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 22.57
|
|
|
| Stock options [member] | 10/08/2018 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
10/08/2018
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
5,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
5,000
|
5,000
|
|
| Maximum of shares to be issued |
5,300
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
5,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 24.8
|
|
|
| Stock options [member] | 04/24/2019 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
04/24/2019
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
904,291
|
|
|
| Number of instruments voided |
(10,500)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
893,791
|
904,291
|
|
| Maximum of shares to be issued |
947,418
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
893,791
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 18.25
|
|
|
| Stock options [member] | 11/06/2019 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
11/06/2019
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
30,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
30,000
|
30,000
|
|
| Maximum of shares to be issued |
31,800
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
30,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 11.06
|
|
|
| Stock options [member] | 07/20/2020 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
07/20/2020
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
17,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
17,000
|
17,000
|
|
| Maximum of shares to be issued |
18,020
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
17,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 15.12
|
|
|
| Stock options [member] | 08/05/2020 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
08/05/2020
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
114,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
114,000
|
114,000
|
|
| Maximum of shares to be issued |
120,840
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
114,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 14.62
|
|
|
| Stock options [member] | 11/05/2020 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
11/05/2020
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
20,500
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
20,500
|
20,500
|
|
| Maximum of shares to be issued |
21,730
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
20,500
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 14.62
|
|
|
| Stock options [member] | 03/04/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/04/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
654,881
|
|
|
| Number of instruments voided |
(14,780)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
640,102
|
654,881
|
|
| Maximum of shares to be issued |
678,508
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
639,610
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 19.44
|
|
|
| Stock options [member] | 04/13/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
04/13/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
27,465
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
27,465
|
27,465
|
|
| Maximum of shares to be issued |
29,113
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
27,465
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 16.07
|
|
|
| Stock options [member] | 05/12/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/12/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
2,844
|
|
|
| Number of instruments voided |
(2,844)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
2,844
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 14.36
|
|
|
| Stock options [member] | 05/28/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/28/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
25,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
25,000
|
25,000
|
|
| Maximum of shares to be issued |
26,500
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
25,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 12.69
|
|
|
| Stock options [member] | 09/30/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
09/30/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
450
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
450
|
450
|
|
| Maximum of shares to be issued |
477
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
450
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 11.51
|
|
|
| Stock options [member] | 11/25/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
11/25/2021
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
3,094
|
|
|
| Number of instruments voided |
(3,094)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
3,094
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 8.81
|
|
|
| Stock options [member] | 03/03/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/03/2022
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
499,045
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
499,045
|
499,045
|
|
| Maximum of shares to be issued |
528,988
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
494,759
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 4.41
|
|
|
| Stock options [member] | 03/29/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/29/2022
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
3,400
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
3,400
|
3,400
|
|
| Maximum of shares to be issued |
3,604
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
3,188
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 3.96
|
|
|
| Stock options [member] | 05/24/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/24/2022
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
37,580
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
37,580
|
37,580
|
|
| Maximum of shares to be issued |
39,835
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
37,258
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 3.48
|
|
|
| Stock options [member] | 12/19/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
12/19/2022
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,255
|
|
|
| Number of instruments voided |
(1,255)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
1,255
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.09
|
|
|
| Stock options [member] | 01/24/2023 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
01/24/2023
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,084,941
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
1,084,941
|
1,084,941
|
|
| Maximum of shares to be issued |
1,150,037
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
691,956
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 3.17
|
|
|
| Stock options [member] | 05/04/2023 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/04/2023
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
355,650
|
|
|
| Number of options/warrants exercised |
(300)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
355,350
|
355,650
|
|
| Maximum of shares to be issued |
376,671
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
233,681
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.8
|
|
|
| Stock options [member] | 06/26/2023 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
06/26/2023
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
46,753
|
|
|
| Number of options/warrants exercised |
(2,000)
|
|
|
| Number of instruments voided |
(2,656)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
42,096
|
46,753
|
|
| Maximum of shares to be issued |
44,622
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
26,088
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.74
|
|
|
| Stock options [member] | 01/25/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
01/25/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,412,476
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
1,412,476
|
1,412,476
|
|
| Maximum of shares to be issued |
1,497,225
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
466,117
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.6
|
|
|
| Stock options [member] | 05/15/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/15/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
571,625
|
|
|
| Number of options/warrants exercised |
(2,742)
|
|
|
| Number of instruments voided |
(34,533)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
534,350
|
571,625
|
|
| Maximum of shares to be issued |
534,350
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
201,006
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.82
|
|
|
| Stock options [member] | 06/26/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
06/26/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
556,562
|
|
|
| Number of options/warrants exercised |
(8,396)
|
|
|
| Number of instruments voided |
(2,530)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
545,636
|
556,562
|
|
| Maximum of shares to be issued |
545,636
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
190,537
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.07
|
|
|
| Stock options [member] | 08/07/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
08/07/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
100,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
100,000
|
100,000
|
|
| Maximum of shares to be issued |
100,000
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
33,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.9
|
|
|
| Stock options [member] | 09/05/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
09/05/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
21,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
21,000
|
21,000
|
|
| Maximum of shares to be issued |
21,000
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
6,563
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.08
|
|
|
| Stock options [member] | 11/04/2024 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
11/04/2024
|
|
|
| Type |
Stock Options
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
19,675
|
|
|
| Number of instruments voided |
(9,800)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
9,875
|
19,675
|
|
| Maximum of shares to be issued |
9,875
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
2,469
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.7
|
|
|
| Stock options [member] | 1/30/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
01/30/2025
|
|
|
| Type |
Stock Options
|
|
|
| Number shares granted |
3,851,783
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
3,851,783
|
|
|
| Maximum of shares to be issued |
3,851,783
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.56
|
|
|
| Stock options [member] | 3/13/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/13/2025
|
|
|
| Type |
Stock Options
|
|
|
| Number shares granted |
1,866,150
|
|
|
| Number of instruments voided |
(84,625)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
1,781,525
|
|
|
| Maximum of shares to be issued |
1,781,525
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.26
|
|
|
| Stock options [member] | 6/23/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
06/23/2025
|
|
|
| Type |
Stock Options
|
|
|
| Number shares granted |
476,100
|
|
|
| Number of instruments voided |
(4,500)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
471,600
|
|
|
| Maximum of shares to be issued |
471,600
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 1.28
|
|
|
| Stock options [member] | 11/7/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
11/07/2025
|
|
|
| Type |
Stock Options
|
|
|
| Number shares granted |
132,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
132,000
|
|
|
| Maximum of shares to be issued |
132,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 3.07
|
|
|
| Stock options [member] | 12/9/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
12/09/2025
|
|
|
| Type |
Stock Options
|
|
|
| Number shares granted |
20,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
20,000
|
|
|
| Maximum of shares to be issued |
20,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 4.07
|
|
|
| Warrants [member] | 3/27/2015 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/27/2015
|
|
|
| Type |
Warrants
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
50,000
|
|
|
| Number of instruments voided |
(50,000)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
50,000
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 38.45
|
|
|
| Warrants [member] | 9/8/2015 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
09/08/2015
|
|
|
| Type |
Warrants
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
74,200
|
|
|
| Number of instruments voided |
(74,200)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
74,200
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 28.01
|
|
|
| Warrants [member] | 3/14/2016 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/14/2016
|
|
|
| Type |
Warrants
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
66,675
|
|
|
| Number of instruments voided |
(40,175)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
26,500
|
66,675
|
|
| Maximum of shares to be issued |
28,090
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
26,500
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 27.37
|
|
|
| Warrants [member] | 10/28/2016 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
10/28/2016
|
|
|
| Type |
Warrants
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
68,000
|
|
|
| Number of instruments voided |
(40,000)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
28,000
|
68,000
|
|
| Maximum of shares to be issued |
29,680
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
28,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 18.68
|
|
|
| Warrants [member] | 10/11/2017 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
10/11/2017
|
|
|
| Type |
Warrants
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
80,000
|
|
|
| Number of instruments voided |
(40,000)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
40,000
|
80,000
|
|
| Maximum of shares to be issued |
42,400
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
40,000
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 24.34
|
|
|
| Warrants [member] | 8/4/2025 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
08/04/2025
|
|
|
| Type |
Warrants
|
|
|
| Number shares granted |
75,000
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
75,000
|
|
|
| Maximum of shares to be issued |
75,000
|
|
|
| Number of exercisable warrants and stock options as of 12/31/2025 |
23,438
|
|
|
| Exercise price per option / warrant in Euros | € / shares |
€ 2.59
|
|
|
| Free Shares [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
509,295
|
1,017,538
|
909,113
|
| Number shares granted |
0
|
0
|
342,900
|
| Number of free shares vested |
(231,992)
|
(342,675)
|
(167,433)
|
| Number of outstanding instruments as of 12/31/2025 |
251,946
|
509,295
|
1,017,538
|
| Free Shares [member] | 03/05/2021 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/05/2021
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
788
|
|
|
| Number of instruments voided |
(788)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
788
|
|
| Free Shares [member] | 03/03/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/03/2022
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
192,480
|
|
|
| Number of free shares vested |
(192,728)
|
|
|
| Number of instruments voided |
248
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
0
|
192,480
|
|
| Maximum of shares to be issued |
0
|
|
|
| Free Shares [member] | 03/29/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
03/29/2022
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
2,014
|
|
|
| Number of free shares vested |
(2,014)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
2,014
|
|
| Free Shares [member] | 05/24/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
05/24/2022
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
34,856
|
|
|
| Number of free shares vested |
(34,002)
|
|
|
| Number of instruments voided |
(854)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
0
|
34,856
|
|
| Maximum of shares to be issued |
0
|
|
|
| Free Shares [member] | 12/19/2022 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
12/19/2022
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
1,606
|
|
|
| Number of free shares vested |
(636)
|
|
|
| Number of instruments voided |
(970)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
|
1,606
|
|
| Free Shares [member] | 01/24/2023 [member] |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
| Date |
01/24/2023
|
|
|
| Type |
Free shares
|
|
|
| Number of outstanding instruments as of 01/01/2025 |
277,538
|
|
|
| Number of free shares vested |
(2,612)
|
|
|
| Number of instruments voided |
(22,980)
|
|
|
| Number of outstanding instruments as of 12/31/2025 |
251,946
|
277,538
|
|
| Maximum of shares to be issued |
251,946
|
|
|